Methodological studies on the uptake of zinc by 3T3 cells.
In the present work, experiments were conducted on the uptake of zinc by 3T3 cells. (1) The percent Zn uptake gradually decreased with addition of increasing amount of zinc (0.05-8.4 mug). (2) With the increase of the incubation period from 2 to 16 hr, Zn uptake by nearly confluent cells increases gradually; however, confluent cells which are newly replated show a distinct cyclic increase in the Zn uptake after 2, 6, and 10 hr. (3) The amino acids of DMM and serum decrease Zn uptake. (4) Histidine at a molar excess of 1:50, 1:500, and 1:5000 reduces Zn uptake in comparison to a treatment with 65Zn-Zn-L-hist2 at a molar ratio of 1:5. (5) When zinc is added in the form of different Zn compounds, at a molar ratio of 1:2 or 1:1 (Zn:ligand), EDTA decreases the Zn uptake markedly. A small influence was shown also by albumin and histidine; however, other amino and organic acids at a molar ratio of 1:2 did not alter Zn uptake significantly.
D000818:Animals; D002460:Cell Line; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D005029:Ethylenediamines / Q000494:pharmacology; D005650:Fumarates / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D006639:Histidine / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D051379:Mice; D013912:Threonine / Q000494:pharmacology; D013997:Time Factors; D014633:Valine / Q000494:pharmacology; D015032:Zinc / Q000378:metabolism* / Q000494:pharmacology
D003470:Culture Media; D005029:Ethylenediamines; D005650:Fumarates; D013912:Threonine; D006639:Histidine; D014633:Valine; D015032:Zinc; D005998:Glycine